This Week in BMC Cancer | GenomeWeb

This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers at the Cancer Treatment Centers of America present a method that uses quality-of-life assessment as a predictor of survival in patients with non-small-cell lung cancer. The team studied 1,194 lung cancer patients, and found that global quality of life as well as physical function predicted patient survival in the entire study population. "Every 10-point increase in physical function was associated with a 10 percent increase in survival," the authors write.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.